Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarillion Plc Regulatory News (CLLN)

  • This share is currently suspended. It was suspended at a price of 14.27

Share Price Information for Carillion Plc (CLLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.27
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 14.27
CLLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DGAP-UK-Regulatory: Allianz Global Investors - Global Equity Business Unit: Carillion Plc

19 Apr 2011 11:00

Allianz Global Investors - Global Equity Business Unit / Rule 8.3 19.04.2011 12:00 Dissemination of a UK Regulatory Announcement, transmitted byDGAP - a company of EquityStory AG.The issuer is solely responsible for the content of this announcement.--------------------------------------------------------------------------- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the 'Code') 1. KEY INFORMATION (a) Identity of the person whose positions/dealings Allianz Globalare being disclosed: Investors Global Equity Business Unit(b) Owner or controller of interests and shortpositions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient (c) Name of offeror/offeree in relation to whose Carillion Plc relevant securities this form relates: (GB0007365546) Use a separate form for each offeror/offeree (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: 18 April 2011 (f) Has the discloser previously disclosed, Yes, or are they today disclosing, under the Eaga PlcCode in respect of any other party to this offer? 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: Ordinary Shares Interests Short positions Number % Number % (1) Relevant securities owned and/or 11,388,229 2.850controlled: (2) Derivatives (other than options): (3) Options and agreements to purchase/sell: TOTAL: 11,388,229 2.850 All interests and all short positions should be disclosed. Details of any open derivative or option positions, or agreements topurchase or sell relevant securities, should be given on a SupplementalForm 8 (Open Positions). (b) Rights to subscribe for new securities (including directors' and otherexecutive options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: If there are positions or rights to subscribe to disclose in more than oneclass of relevant securities of the offeror or offeree named in 1(c), copytable 2(a) or (b) (as appropriate) for each additional class of relevantsecurity. 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (a) Purchases and sales Class of relevant Purchase/sale Number of Price persecurity securities unitOrdinary Shares Purchase 10,666 GBP 3.812 (b) Derivatives transactions (other than options) Class of Product Nature of dealing e.g. opening/ Number of Pricerelevant descript closing a long/short position, reference persecurity ion e.g. increasing/reducing a long/short securities unit CFD position (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Class Product Writing, Number of Exerc Type e.g. Ex- Optionof descrip- purchasi securities ise American, piry moneyrele- tion e.g. ng, to which price European da- paid/vant call selling, option per etc. te receivedsecu- option varying relates unit per unitrity etc. (ii) Exercising Class of relevant Product descriptione.g. Number of Exercise pricesecurity call option securities per unit (d) Other dealings (including subscribing for new securities) Class of relevant Nature of dealing e.g. Details Price per unit (ifsecurity subscription, conversion applicable) The currency of all prices and other monetary amounts should be stated. Where there have been dealings in more than one class of relevantsecurities of the offeror or offeree named in 1(c), copy table 3(a), (b),(c) or (d) (as appropriate) for each additional class of relevant securitydealt in. 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: If there are no such agreements, arrangements or understandings, state 'none' (b) Agreements, arrangements or understandings relating to options orderivatives Details of any agreement, arrangement or understanding, formal or informal,between the person making the disclosure and any other person relatingto:(i) the voting rights of any relevant securities under any option; or(ii) the voting rights or future acquisition or disposal of any relevantsecurities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state 'none' (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 19 April 2011Contact name: Dr. Sascha SpiegelTelephone number: 0049 89 1220 7570 Public disclosures under Rule 8 of the Code must be made to a RegulatoryInformation Service and must also be emailed to the Takeover Panel atmonitoring@disclosure.org.uk. The Panel's Market Surveillance Unit isavailable for consultation in relation to the Code's dealing disclosurerequirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel's website atwww.thetakeoverpanel.org.uk. 19.04.2011 DGAP's Distribution Services include Regulatory Announcements,Financial/Corporate News and Press Releases.Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: EnglishCompany: Allianz Global Investors - Global Equity Business Unit Seidlstr. 24 - 24 a 80335 München GermanyPhone: +49 (0)89 1220 7570Fax: +49 (0)89 1220 7559E-mail: sascha.spiegel@allianzam.comInternet: www.allianzgi.comISIN: -Category Code: RETLSE Ticker: Sequence Number: 773Time of Receipt: Apr 19, 2011 11:59:54 End of Announcement DGAP News-Service ---------------------------------------------------------------------------

UK-Regulatory-announcement transmitted by DGAP - a company of EquityStory AG.The issuer is solely responsible for the content of this announcement.

Date   Source Headline
3rd Apr 20187:30 amRNSUpdate re Liquidation of Carillion
19th Mar 20187:00 amRNSFRC investigation
17th Jan 20188:15 amRNSAnnouncement Re. Carillion PLC
15th Jan 20187:45 amRNSSuspension - Carillion PLC
15th Jan 20187:00 amRNSCompulsory liquidation of Carillion
12th Jan 20186:08 pmRNSUpdate on discussions with creditors
12th Jan 20185:08 pmRNSHolding(s) in Company
10th Jan 20185:48 pmRNSHolding(s) in Company
9th Jan 20187:03 amRNSResponse to share price movement
3rd Jan 20184:44 pmRNSHolding(s) in Company
3rd Jan 20187:00 amRNSRegulatory investigation
22nd Dec 20177:00 amRNSUpdate on financial covenant deferral
20th Dec 201710:16 amRNSBlock listing Interim Review
20th Dec 20177:00 amRNSChief Executive Appointment
13th Dec 20177:00 amRNSUpdate on UK healthcare facilities business
11th Dec 20177:58 amRNSHolding(s) in Company
1st Dec 20177:00 amRNSDirectorate Change
23rd Nov 201712:08 pmRNSHolding(s) in Company
22nd Nov 201712:29 pmRNSHolding(s) in Company
21st Nov 20174:11 pmRNSHolding(s) in Company
20th Nov 20177:00 amRNSFramework Award
17th Nov 20177:02 amRNSUpdate
15th Nov 20177:00 amRNSOman - letter of award for contract
6th Nov 20177:00 amRNSContract wins
2nd Nov 20177:00 amRNSDirectorate Change
31st Oct 20177:00 amRNSDisposal
27th Oct 20177:00 amRNSChief Executive Appointment
24th Oct 20177:00 amRNSUpdate on financing, disposals and work winning
12th Oct 201712:43 pmRNSUK Healthcare business
4th Oct 20172:58 pmRNSHolding(s) in Company
29th Sep 20177:00 amRNSHalf-year Report
22nd Sep 20171:00 pmRNSHolding(s) in Company
19th Sep 20174:55 pmRNSHolding(s) in Company
11th Sep 20177:00 amRNSDirectorate Change
22nd Aug 20173:17 pmRNSAnnouncement of 2017 interim results
17th Aug 20174:19 pmRNSHolding(s) in Company
15th Aug 20175:58 pmRNSHolding(s) in Company
11th Aug 20176:20 pmRNSHolding(s) in Company
8th Aug 20173:59 pmRNSHolding(s) in Company
8th Aug 201710:02 amRNSHolding(s) in Company
3rd Aug 20179:02 amRNSHolding(s) in Company
1st Aug 201712:24 pmRNSHolding(s) in Company
31st Jul 20172:57 pmRNSHolding(s) in Company
27th Jul 20176:28 pmRNSHolding(s) in Company
18th Jul 201710:49 amRNSHolding(s) in Company
18th Jul 20177:00 amRNSCarillion JV awarded two further HESTIA contracts
17th Jul 20177:19 amRNSHS2 Contract Award
17th Jul 20177:00 amRNSCarillion appoints EY to support strategic review
14th Jul 201712:20 pmRNSHolding(s) in Company
14th Jul 20177:00 amRNSAppointment of Joint Financial Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.